P. Kwon

发表

Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.

F. Lombardo, P. Atadja, S. Whitebread, 2011, Journal of medicinal chemistry.

Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824

P. Atadja, D. Cohen, P. Lassota, 2004, Cancer Research.

Organismal aging and phosphorylation of transcription factors

P. Atadja, P. Kwon, 2004 .

N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).

P. Atadja, P. Lassota, K. Bair, 2003, Journal of medicinal chemistry.

Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824.

P. Atadja, K. Bhalla, Meier Hsu, 2004, Novartis Foundation symposium.

Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T‐cell lymphoma models: Defining molecular mechanisms of resistance

P. Atadja, S. Fawell, W. Shao, 2010, International journal of cancer.

Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation.

P. Kwon, Y. Yan-Neale, R. Cai, 2001, Biochemical and biophysical research communications.

PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies

Anu V. Connor, Yan Tang, Angela Tam, 2021, Molecular Cancer Therapeutics.

Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.

Manfred Jung, W. Cornell, P. Atadja, 2002, Journal of medicinal chemistry.

Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects*

D. Cohen, S. Zabludoff, P. Kwon, 1999, The Journal of Biological Chemistry.

Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells.

D. Cohen, P. Kwon, R. Rzepka, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors

Anu V. Connor, W. Sellers, K. Mansfield, 2018, Clinical Cancer Research.